The Life Sciences Café is back! Organised by Amsterdam Economic Board and EY. The theme of this edition is the valorisation of biotech ideas and technology, entrepreneurship and biotech innovation ecosystems and scaling up from a life sciences startup to scale-up.
Dr. Sanne Weijzen, VP Corporate Strategy at Neogene Therapeutics, talks about the growth of this American/Dutch biotech scale-up. Prof. Davide Iannuzzi, Chief Impact Officer of the Vrije Universiteit Amsterdam (VU Amsterdam), will update you on the Biotech Booster program that was recently awarded 250 million euros in funding by the Groeifonds.